# CERS5

## Overview
CERS5 is a gene that encodes the enzyme ceramide synthase 5, a transmembrane protein primarily located in the endoplasmic reticulum. This enzyme is integral to the biosynthesis of ceramides, specifically C16-ceramide, which are sphingolipids involved in various cellular processes, including apoptosis and cell signaling (Mullen2012Ceramide; Stiban2010Ceramide). The CERS5 protein is characterized by multiple transmembrane domains and contains a TRAM-Lag-CLN8 (TLC) domain, which is essential for its enzymatic activity (Zelnik2019A; Stiban2010Ceramide). CERS5 plays a significant role in maintaining cellular homeostasis and is implicated in immune responses and inflammation (ElHindi2020Ceramide). Alterations in CERS5 expression have been associated with various cancers, indicating its potential as a biomarker for prognosis in certain cancer types (Jang2018Altered; Zhang2022High).

## Structure
Ceramide synthase 5 (CERS5) is an integral membrane protein involved in the synthesis of C16-ceramide, a type of sphingolipid. The protein is located in the endoplasmic reticulum and is characterized by multiple transmembrane domains. Predictions suggest that CERS5 has six transmembrane domains, with the N-terminus and C-terminus positioned on opposite sides of the ER membrane (Zelnik2019A; Mullen2012Ceramide). The first transmembrane domain is crucial for its insertion into the ER membrane (Zelnik2019A).

CERS5 contains a TRAM-Lag-CLN8 (TLC) domain, which includes the Lag1p motif essential for its enzymatic activity (Zelnik2019A; Stiban2010Ceramide). This motif is critical for the protein's function in ceramide synthesis. Post-translational modifications, such as phosphorylation, regulate CERS5 activity, with protein kinase C (PKC) activation enhancing its function (Stiban2010Ceramide).

While specific details on the primary, secondary, tertiary, or quaternary structures of CERS5 are not provided, the protein's functional domains and post-translational modifications are well-documented. The presence of splice variant isoforms is not mentioned in the available context.

## Function
Ceramide synthase 5 (CERS5) is an enzyme involved in the synthesis of ceramides, specifically C16-ceramide, which plays a significant role in cellular processes such as apoptosis and cell signaling. CERS5 is active in the endoplasmic reticulum, where it catalyzes the formation of ceramides by linking fatty acids to sphingosine, contributing to the maintenance of cell membrane integrity and signaling pathways (Mullen2012Ceramide; Stiban2010Ceramide).

In healthy human cells, CERS5 is crucial for regulating ceramide levels, which are important for cell membrane structure and function. C16-ceramide, produced by CERS5, is involved in apoptosis, a form of programmed cell death essential for cellular homeostasis and development (Stiban2010Ceramide). This ceramide species is considered pro-apoptotic and can influence mitochondrial function, leading to oxidative stress and cell death (Park2014Ceramide).

CERS5 also plays a role in immune responses and inflammation. It is involved in T-cell activation and cytokine regulation, which are essential for immune function. Deficiency in CERS5 has been shown to impair T-cell activation and exacerbate inflammatory conditions, highlighting its role in maintaining immune cell populations and modulating inflammation (ElHindi2020Ceramide).

## Clinical Significance
Alterations in the expression of the CERS5 gene have been implicated in various cancers. In colorectal cancer (CRC), CERS5 mRNA levels are significantly upregulated in tumor tissues compared to non-tumor tissues, although this upregulation does not correlate with clinicopathological parameters such as age, sex, or tumor stage, suggesting that while CERS5 expression is altered, it may not directly impact clinical outcomes in CRC (Jang2018Altered).

In gastric cancer, high expression levels of CERS5 are associated with a poor prognosis, particularly in Asian populations. This association is supported by data from the Asian Cancer Research Group, which indicates that patients with elevated CERS5 expression have a significantly lower 5-year survival rate. CERS5 is also upregulated in metastatic lymph nodes, and its high expression is considered an independent risk factor for poor prognosis (Zhang2022High).

In non-small cell lung cancer (NSCLC), high mRNA expression of CERS5 is linked to improved overall survival in adenocarcinoma patients, but not in those with squamous cell carcinoma, highlighting a context-dependent role of CERS5 in lung cancer prognosis (Qian2020Ceramide).

## Interactions
Ceramide synthase 5 (CERS5) is involved in various protein interactions that influence its function and activity. CERS5 forms hetero-complexes and dimers with other ceramide synthases, such as CerS2 and CerS6, which modulate its enzymatic activity. The activity of CerS2 is enhanced by co-expression with catalytically active forms of CERS5, indicating a functional interaction between these enzymes (Park2014Ceramide). In HeLa cells, CERS5 and CerS6 contribute to radiation-induced apoptosis, and co-immunoprecipitation studies suggest that CERS5 may form heterocomplexes with CerS2 and CerS6, indicating potential physical interactions among these proteins (Mesicek2010Ceramide).

CERS5 is also implicated in the mitochondrial apoptotic pathway, as its overexpression increases apoptosis, which can be abrogated by co-overexpression with Bcl-xL, a known anti-apoptotic protein. This suggests an interaction between CERS5 and Bcl-xL in regulating apoptosis (Mesicek2010Ceramide). Additionally, CERS5 is involved in lipid-induced autophagy and hypertrophy in cardiomyocytes, where it influences the expression of autophagy-related proteins like Beclin 1 (BECN1), although specific physical interactions with these proteins are not detailed (Russo2012Ceramide). There is no evidence of direct interactions between CERS5 and nucleic acids in the provided context.


## References


[1. (Zhang2022High) Shengjie Zhang, Yi Wang, Li Yuan, Can Hu, Zhiyuan Xu, and Xiangdong Cheng. High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer. Translational Cancer Research, 11(9):3209–3221, September 2022. URL: http://dx.doi.org/10.21037/tcr-22-1348, doi:10.21037/tcr-22-1348. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.21037/tcr-22-1348)

[2. (Qian2020Ceramide) Huijiang Qian, Jingjing Deng, Chao Lu, Gouxin Hou, Hualiang Zhang, Ming Zhang, Zhixian Fang, and Xiao-Dong Lv. Ceramide synthases: insights into the expression and prognosis of lung cancer. Experimental Lung Research, 47(1):37–53, November 2020. URL: http://dx.doi.org/10.1080/01902148.2020.1844345, doi:10.1080/01902148.2020.1844345. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/01902148.2020.1844345)

[3. (Russo2012Ceramide) Sarah Brice Russo, Catalin F. Baicu, An Van Laer, Tuoyu Geng, Harinath Kasiganesan, Michael R. Zile, and L. Ashley Cowart. Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes. Journal of Clinical Investigation, 122(11):3919–3930, October 2012. URL: http://dx.doi.org/10.1172/jci63888, doi:10.1172/jci63888. This article has 173 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci63888)

[4. (Stiban2010Ceramide) Johnny Stiban, Rotem Tidhar, and Anthony H. Futerman. Ceramide Synthases: Roles in Cell Physiology and Signaling, pages 60–71. Springer New York, 2010. URL: http://dx.doi.org/10.1007/978-1-4419-6741-1_4, doi:10.1007/978-1-4419-6741-1_4. This article has 131 citations.](https://doi.org/10.1007/978-1-4419-6741-1_4)

[5. (ElHindi2020Ceramide) Khadija El-Hindi, Sebastian Brachtendorf, Jennifer Christina Hartel, Stephanie Oertel, Kerstin Birod, Sandra Trautmann, Dominique Thomas, Thomas Ulshöfer, Andreas Weigert, Olaf Utermöhlen, Martin Krönke, and Sabine Grösch. Ceramide synthase 5 deficiency aggravates dextran sodium sulfate-induced colitis and colon carcinogenesis and impairs t-cell activation. Cancers, 12(7):1753, July 2020. URL: http://dx.doi.org/10.3390/cancers12071753, doi:10.3390/cancers12071753. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers12071753)

[6. (Park2014Ceramide) Joo-Won Park, Woo-Jae Park, and Anthony H. Futerman. Ceramide synthases as potential targets for therapeutic intervention in human diseases. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1841(5):671–681, May 2014. URL: http://dx.doi.org/10.1016/j.bbalip.2013.08.019, doi:10.1016/j.bbalip.2013.08.019. This article has 180 citations.](https://doi.org/10.1016/j.bbalip.2013.08.019)

[7. (Mesicek2010Ceramide) Judith Mesicek, Hyunmi Lee, Taya Feldman, Xuejun Jiang, Anastasia Skobeleva, Evgeny V. Berdyshev, Adriana Haimovitz-Friedman, Zvi Fuks, and Richard Kolesnick. Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in hela cells. Cellular Signalling, 22(9):1300–1307, September 2010. URL: http://dx.doi.org/10.1016/j.cellsig.2010.04.006, doi:10.1016/j.cellsig.2010.04.006. This article has 176 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2010.04.006)

[8. (Jang2018Altered) Sung Jang, Woo‑Jae Park, Hyeonji Min, Taeg Kwon, Seong Baek, Ilseon Hwang, Shin Kim, and Jong‑Wook Park. Altered mrna expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer. Oncology Reports, September 2018. URL: http://dx.doi.org/10.3892/or.2018.6712, doi:10.3892/or.2018.6712. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2018.6712)

[9. (Mullen2012Ceramide) Thomas D. Mullen, Yusuf A. Hannun, and Lina M. Obeid. Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochemical Journal, 441(3):789–802, January 2012. URL: http://dx.doi.org/10.1042/bj20111626, doi:10.1042/bj20111626. This article has 403 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20111626)

[10. (Zelnik2019A) Iris D. Zelnik, Batsheva Rozman, Eden Rosenfeld-Gur, Shifra Ben-Dor, and Anthony H. Futerman. A Stroll Down the CerS Lane, pages 49–63. Springer International Publishing, 2019. URL: http://dx.doi.org/10.1007/978-3-030-21162-2_4, doi:10.1007/978-3-030-21162-2_4. This article has 38 citations.](https://doi.org/10.1007/978-3-030-21162-2_4)